Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14, 2021 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in Irvine, California and online on June 29, 2021.

Detailed results of the vote for the election of directors are set out below:

Name of Nominee	Votes For	% Votes For		Votes Withheld	% Votes Withheld
Dr. Khalid Islam	13,646,934	99.05%		130,590	0.95%
Mr. Adrian Haigh	13,419,749	97.40%		357,775	2.60%
Mr. Chris A. Rallis	13,611,818	98.80%		165,706	1.20%
Dr. Marco Brughera	13,517,839	98.12%		259,685	1.88%
Dr. Jodi Cook	13,519,400	98.13%		258,124	1.87%
Mr. Rostislav Raykov	13,656,957	99.12%		120,567	0.88%

Shareholders also voted 99.88% in favour of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, and voted 97.48% in favour of the compensation paid to the Company’s named executive officers.

For further information, please contact:

Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: [phone]